Accepted at 8:31 p.m. Oct, 31, 2023 by Alex
Author: kidCoLa
Related Note: 1480564293791
Rationale for change

extra space

Text Text
Extra
- Myelodysplastic syndromes are stem-cell disorders involving ineffective hematopoiesis; results in defects in cell maturation of all nonlymphoid lineages

- Myeloproliferative includes essential thrombocythemia, polycythemia vera, primary myelofibrosis, chronic myeloid leukemia

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
OME

Additional Resources
Other:
One by one
Empty field
#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step2_v12::#AMBOSS::KS0U0f #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::27_Myelodysplastic_syndromes #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::03_Acute_Leukemias::Extra #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders::Extra #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step1_v12::#AMBOSS::41a3Sj #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::12_Acute_Leukemia #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step2_v12::!Shelf::IM::no_dupes !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia !AK_UpdateTags::AnKing_Image::Mujeeb #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::07_Myeloproliferative_Disorders::Extra #AK_Step2_v12::#AMBOSS::vt0A23 !AK_UpdateTags::AnKing_Image::Mujeeb::Leukemia_and_Lymphoma_Overview #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::01_Myeloproliferative_Neoplasms_&_Myelodysplastic_Syndromes #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::28_Leukemias::*Leukemia::Acute_Leukemia::Acute_Myelogenous_Leukemia::Myelodysplastic_Syndromes #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::02_Acute_Myeloid_Leukemia_(AML)_&_Chronic_Myeloid_Leukemia_(CML) #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::01_Acute_Leukemia::Extra #AK_Step1_v12::#Pathoma::06_WBC::02_Acute_Leukemia #AK_Step1_v12::^Other::^HighYield::3-HighYield-temporary #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::04_Myelofibrosis_and_Myelodysplastic_Syndromes #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::01_Acute_Leukemias_SOAP #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::01_Acute_Myeloid_Leukemia #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::01_Acute_Myelogenous_Leukemia_(AML) #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::28_Leukemias::*Leukemia::Acute_Leukemia::Acute_Myelogenous_Leukemia::Basics